eVia Labs production building at the manufacturing facility

Pharmaceutical rigor.
Industrial-scale execution.

Operating state-of-the-art modular Class 100,000 / engineered under stringent WHO-GMP guidelines. eVia Labs converges advanced cGMP standard operating procedures with pharmaceutical-grade solid oral dose and encapsulation.

Confidential technical dossiers & protocol consultations upon NDA

Pharma Experience
20+ Years
Founding team in the pharmaceutical industry
Dosage Formats
3 Formats
Tablets, capsules and powders
Certified Plant
WHO-GMP
ISO 9001:2015, Halal & Kosher certified
Packaging
Ready-to-Sell
Containers, Alu-Alu & blister packs, sachets

The 6-Stage Manufacturing
Validation Workflow.

From molecule sourcing through commercial batch dispatch, every milestone requires formal analytical clearance and quality oversight before stage progression.

  1. STAGE 01

    Formulation & Feasibility

    Excipient compatibility screening, flowability profiling, and botanical active stabilization.

    Gate: Pre-formulation Report

  2. STAGE 02

    Pilot Sampling & Validation

    Small-scale pilot batches, hardness curves, disintegration runs, and client sign-off.

    Gate: Pilot CoA & Client Approval

  3. STAGE 03

    Dossier & Licensing

    Regulatory filing support and FSSAI product category endorsement.

    Gate: Regulatory Clearance Dossier

  4. STAGE 04

    Commercial Production

    Full scale blending, compression, or encapsulation under monitored cleanroom HVAC specifications.

    Gate: Batch Manufacturing Record

  5. STAGE 05

    QA & Analytical Release

    Complete microbiological testing, heavy metals screening, assay checks, and QA document sign-off.

    Gate: Final Release Certificate

  6. STAGE 06

    Packaging & Dispatch

    Hermetic sealing, tamper-evident outer boxing and ambient staging.

    Gate: Commercial Dispatch Waybill

Zero-Compromise
Quality Control Architecture.

“Many manufacturers can make a product once. Few can repeat it with identical purity, dissolution timing, and assay records across every single cycle.”
— Head of Quality Operations, eVia Labs

Our quality verification protocol operates autonomously from commercial manufacturing schedules. Analytical release requires uncompromised quantitative passes at all three verification checkpoints.

L1INCOMING VALIDATION

Raw Material Quarantine & FTIR / HPLC Assay

100% of botanical extracts, active vitamins, and functional minerals undergo spectroscopic identity verification, moisture analysis, bulk density validation, and assay qualification before automated release into active inventory.

L2IN-LINE PROCESS

In-Process Quality Controls (IPQC)

Continuous sampling every 30 minutes during active production runs. Tablet thickness, hardness profiling, friability (<0.8%), disintegration time checks, and capsule fill weight dispersion indexing ensure batch uniformity.

L3FINISHED RELEASE

Finished Product Release Criteria

Comprehensive Certificate of Analysis (CoA) generation including active potency retention, stability assay, dissolution curves, microbial absence (E. coli, Salmonella, S. aureus), and leak integrity testing for blisters.

Our Certifications

Our manufacturing facility is independently certified for the manufacture of food and health supplements and nutraceuticals.

  • MQA Certification logo

    WHO-GMP

    Good Manufacturing Practice

    Issued by MQA Certification

  • United Accreditation logo

    ISO 9001:2015

    Quality Management System

    Issued by United Accreditation

  • UKAF Cert logo

    HALAL

    Certificate of Compliance

    Issued by UKAF Cert

  • MQA Certification logo

    KOSHER

    Certificate of Compliance

    Issued by MQA Certification

Request a Comprehensive
Technical Dossier.

Review our cleanroom parameters, HVAC protocols, and analytical chromatography specifications. We provide complete technical batch dossiers and consultation sessions upon NDA.